According to Taiji Group, recently, China Taiji and JD Health have signed a strategic cooperation agreement. In the future, the two parties will focus on the '1+5+N' strategy, leveraging the advantages of the JD Health platform, with the Huoxiang Zhengqi Oral Solution as a representative of the digestive system drugs as the core, strengthening the five key categories of respiratory, tonifying, ophthalmic, analgesic, and traditional Chinese medicine decoction, incubating N advantageous varieties. The two parties will explore deeply in the field of traditional Chinese medicine and jointly build a new digital health ecosystem for traditional Chinese medicine.